Literature DB >> 23579436

Alu-mediated nonallelic homologous and nonhomologous recombination in the BMPR2 gene in heritable pulmonary arterial hypertension.

Masaharu Kataoka1, Yuki Aimi, Ryoji Yanagisawa, Masae Ono, Akira Oka, Keiichi Fukuda, Hideaki Yoshino, Toru Satoh, Shinobu Gamou.   

Abstract

PURPOSE: The purpose of this study was to undertake thorough genetic analysis of the bone morphogenetic protein type 2 receptor (BMPR2) gene in patients with pulmonary arterial hypertension.
METHODS: We conducted a systematic analysis for larger gene rearrangements together with conventional mutation analysis in 152 pulmonary arterial hypertension patients including 43 patients diagnosed as having idiopathic pulmonary arterial hypertension and 10 diagnosed as having familial pulmonary arterial hypertension.
RESULTS: Analysis of the BMPR2 gene revealed each of the four kinds of nonsense and frameshift mutations, one missense mutation, one splice-site mutation, and two types of exonic deletion. For cases in which exons 1-3 were deleted, the 5' and 3' break points were located in the AluY repeat sequences in the 5' side of the adjacent NOP58 gene and in the AluY repeat sequences in intron 3, suggesting an AluY-mediated nonallelic homologous recombination as the mechanism responsible for the deletion. For the case in which exon 10 was deleted, nonhomologous recombination took place between the AluSx site in intron 9 and a unique sequence in intron 10.
CONCLUSION: Exonic deletions of BMPR2 account for at least part of BMPR2 mutations associated with heritable pulmonary arterial hypertension in Japan, as previously reported in other populations. One of our cases was mediated via Alu-mediated nonallelic homologous recombination and another was mediated via nonhomologous recombination.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23579436     DOI: 10.1038/gim.2013.41

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  8 in total

Review 1.  Structural Variation of Alu Element and Human Disease.

Authors:  Songmi Kim; Chun-Sung Cho; Kyudong Han; Jungnam Lee
Journal:  Genomics Inform       Date:  2016-09-30

2.  Dual loss of human POLQ and LIG4 abolishes random integration.

Authors:  Shinta Saito; Ryo Maeda; Noritaka Adachi
Journal:  Nat Commun       Date:  2017-07-11       Impact factor: 14.919

3.  Age-Associated ALU Element Instability in White Blood Cells Is Linked to Lower Survival in Elderly Adults: A Preliminary Cohort Study.

Authors:  R Garrett Morgan; Massimo Venturelli; Cole Gross; Cantor Tarperi; Federico Schena; Carlo Reggiani; Fabio Naro; Anna Pedrinolla; Lucia Monaco; Russell S Richardson; Anthony J Donato
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

4.  Autoimmune hypophysitis as a cause of adrenocorticotropic hormone deficiency in pulmonary arterial hypertension: a case report.

Authors:  Genki Ichihara; Masaharu Kataoka; Yoshinori Katsumata; Keiichi Fukuda
Journal:  Eur Heart J Case Rep       Date:  2021-03-31

5.  Cardiometabolic diseases and related complications: current status and future perspective.

Authors:  Joseph Fomusi Ndisang; Sharad Rastogi
Journal:  Biomed Res Int       Date:  2013-10-09       Impact factor: 3.411

6.  Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic Study.

Authors:  Christina A Eichstaedt; Jeremias Verweyen; Michael Halank; Nicola Benjamin; Christine Fischer; Eckhard Mayer; Stefan Guth; Christoph B Wiedenroth; Benjamin Egenlauf; Satenik Harutyunova; Panagiota Xanthouli; Alberto M Marra; Heinrike Wilkens; Ralf Ewert; Katrin Hinderhofer; Ekkehard Grünig
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

7.  Triple oral combination therapy with macitentan, riociguat, and selexipag for pulmonary arterial hypertension.

Authors:  Mizuki Momoi; Takahiro Hiraide; Yoshiki Shinya; Hiromi Momota; Shogo Fukui; Michiyuki Kawakami; Yuji Itabashi; Keiichi Fukuda; Masaharu Kataoka
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031

8.  Altered DNA repair creates novel Alu/Alu repeat-mediated deletions.

Authors:  Maria E Morales; Tiffany Kaul; JaNiece Walker; Chelsea Everett; Travis White; Prescott Deininger
Journal:  Hum Mutat       Date:  2021-03-19       Impact factor: 4.878

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.